Kennedy Capital Management, Inc. Verona Pharma PLC Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 358,447 shares of VRNA stock, worth $12.7 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
358,447
Previous 337,535
6.2%
Holding current value
$12.7 Million
Previous $4.88 Million
111.31%
% of portfolio
0.24%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
160Shares Held
68.4MCall Options Held
667KPut Options Held
643K-
Perceptive Advisors LLC New York, NY6.32MShares$223 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$198 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$177 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$149 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$126 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.16B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...